BioRestorative Therapies Inc. (BRTX) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    BioRestorative Therapies ...

    NASDAQ: BRTX · Real-Time Price · USD
    1.47
    -0.03 (-2.00%)
    At close: Oct 06, 2025, 2:46 PM

    BioRestorative Therapies Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -1.24 -0.7 -0.75 -0.12
    PEG Ratio
    		 0.02 0.02 0.01 -0.00
    PS Ratio
    		 27.69 50.33 83.05 112.06
    PB Ratio
    		 1.30 0.73 0.97 0.24
    P/FCF Ratio
    		 -1.33 -1.11 -1.58 -1.53
    P/OCF Ratio
    		 -1.35 -1.14 -1.69 -1.55
    OCF/S Ratio
    		 -20.52 -44.1 -49 -72.39
    Debt / Equity Ratio
    		 n/a 0.02 0.03 0.03
    Quick Ratio
    		 2.97 4.37 2.53 59.01
    Current Ratio
    		 2.97 4.37 2.53 59.01
    Asset Turnover
    		 0.03 0.01 0.01 0.00
    Interest Coverage
    		 n/a n/a n/a -14.49
    Return on Equity
    		 -1.05 -1.04 -1.28 -2.05
    Return on Assets
    		 -0.73 -0.83 -0.8 -1.97
    Return on Invested Capital
    		 -1.35 -1.47 -1.7 -0.8
    Dividend Yield
    		 0.06 n/a n/a n/a
    Payout Ratio
    		 -0.07 n/a n/a n/a
    Gross Profit Margin
    		 0.93 -0.14 1.00 1.00
    Net Profit Margin
    		 -22.39 -71.45 -110.37 -963.12
    Pretax Profit Margin
    		 -22.39 -71.45 -110.37 -963.12
    Operating Profit Margin
    		 -28.82 -104.39 -158.38 -571.91
    FCF Margin
    		 -20.79 -45.28 -52.68 -73.06
    EBITDA Margin
    		 -28.34 -70.32 -157.37 -569.97

    Add to Watchlist